chr7-148409383-C-CTT
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_014141.6(CNTNAP2):c.3716-7_3716-6insTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 1,578,214 control chromosomes in the GnomAD database, including 252,035 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.57 ( 25625 hom., cov: 33)
Exomes 𝑓: 0.56 ( 226410 hom. )
Consequence
CNTNAP2
NM_014141.6 splice_region, intron
NM_014141.6 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.173
Publications
3 publications found
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 7-148409383-C-CTT is Benign according to our data. Variant chr7-148409383-C-CTT is described in ClinVar as Benign. ClinVar VariationId is 516869.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.652 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | NM_014141.6 | c.3716-7_3716-6insTT | splice_region_variant, intron_variant | Intron 22 of 23 | ENST00000361727.8 | NP_054860.1 | ||
| LOC105375554 | XR_928094.2 | n.210-14692_210-14691insAA | intron_variant | Intron 1 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.574 AC: 86906AN: 151482Hom.: 25607 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
86906
AN:
151482
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.293 AC: 59553AN: 203228 AF XY: 0.303 show subpopulations
GnomAD2 exomes
AF:
AC:
59553
AN:
203228
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.556 AC: 793079AN: 1426614Hom.: 226410 Cov.: 30 AF XY: 0.558 AC XY: 396955AN XY: 711266 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
793079
AN:
1426614
Hom.:
Cov.:
30
AF XY:
AC XY:
396955
AN XY:
711266
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
21506
AN:
32632
American (AMR)
AF:
AC:
13837
AN:
44570
Ashkenazi Jewish (ASJ)
AF:
AC:
12007
AN:
25858
East Asian (EAS)
AF:
AC:
13972
AN:
39460
South Asian (SAS)
AF:
AC:
52508
AN:
85412
European-Finnish (FIN)
AF:
AC:
34598
AN:
53084
Middle Eastern (MID)
AF:
AC:
2697
AN:
5702
European-Non Finnish (NFE)
AF:
AC:
609584
AN:
1080750
Other (OTH)
AF:
AC:
32370
AN:
59146
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.385
Heterozygous variant carriers
0
15789
31577
47366
63154
78943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
16646
33292
49938
66584
83230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.574 AC: 86958AN: 151600Hom.: 25625 Cov.: 33 AF XY: 0.570 AC XY: 42224AN XY: 74094 show subpopulations
GnomAD4 genome
AF:
AC:
86958
AN:
151600
Hom.:
Cov.:
33
AF XY:
AC XY:
42224
AN XY:
74094
show subpopulations
African (AFR)
AF:
AC:
27225
AN:
41346
American (AMR)
AF:
AC:
5982
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
1614
AN:
3458
East Asian (EAS)
AF:
AC:
1920
AN:
5146
South Asian (SAS)
AF:
AC:
2968
AN:
4804
European-Finnish (FIN)
AF:
AC:
6905
AN:
10554
Middle Eastern (MID)
AF:
AC:
121
AN:
292
European-Non Finnish (NFE)
AF:
AC:
38676
AN:
67742
Other (OTH)
AF:
AC:
1128
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1745
3490
5236
6981
8726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1794
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cortical dysplasia-focal epilepsy syndrome Benign:2
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Nov 19, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.